Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: An overview from Kuwait

Vaccine

Volumn 30, Issue SUPPL. 6, 2012, Pages

  Mokaddas, Eiman ^a   Albert, M John ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Pneumococcal conjugate vaccines; S. pneumoniae; Vaccine coverage

Indexed keywords

ANTISERUM; PENICILLIN G; PNEUMOCOCCAL CONJUGATE VACCINE; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; BACTERIUM ISOLATE; CEREBROSPINAL FLUID; CHILD; EPSILOMETER TEST; FEMALE; GROUPS BY AGE; HUMAN; KUWAIT; MALE; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; SEROTYPE; STREPTOCOCCUS PNEUMONIAE ISOLATE; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KUWAIT; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; PENICILLIN RESISTANCE; PENICILLINS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PREVALENCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE; YOUNG ADULT;

EID: 84870787984     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.10.061     Document Type: Review

References (13)

1. World Health Organization Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly Epidemiol Rec 2007, 82:93-104.
2. Twum-Danso K., Al-Mazrou A.M., Kambal A.M., AI-Zamil F.A. Penicillin resistance in serogroups/serotypes of Streptococcus pneumoniae causing invasive infections in Central Saudi Arabia. Saudi Med J 2003, 24:1210-1213.
3. Felmingham D., Gruneberg R.N., The Alexander Project Group The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother 2000, 45:191-203.
4. Mokaddas E.M., Wilson S., Sanyal S.C. Prevalence of penicillin-resistant Streptococcus pneumoniae in Kuwait. J Chemother 2001, 13(2):154-160.
5. WHO Initiative for Vaccine Research Division Acute respiratory infections, Streptococcus pneumoniae September 2009, Available at: http://www.who.int/vaccine_research/diseases/ari/en/index3.html (accessed 23.09.12).
6. American Academy of Pediatrics Committee on Infectious Disease Policy statement: recommendations for the prevention of pneumococcal conjugate vaccine (Prevnar). Pediatrics 2000, 106:362-366.
7. World Health Organization Progress in introduction of pneumococcal conjugate vaccine-worldwide, 2000-2008. MMWR 2008, 57:1148-1151.
8. Centers for Disease Control and Prevention (CDC) Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000, 49:1-35.
9. Centers for Disease Control and Prevention Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine-United States 2007. MMWR 2010, 59(9):253-257.
10. Shibl A., Memish Z., Pelton S. Epidemiology of invasive pneumococcal disease in the Arabian Peninsula and Egypt. Int J Antimicrob Agents 2009, 33:410.e1-410.e9.
11. Mokaddas E.M., Rotimi V.O., Albert M.J. Implications of Streptococcus pneumoniae penicillin resistance and serotypes Distribution in Kuwait for disease treatment and prevention. Clin Vaccine Immunol 2008, 15:203-207.
12. Skov Sorensen U.B. Typing of pneumococci by using 12 pooled antisera. J Clin Microbiol 1993, 31:2097-2100.
13. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; 15th informational supplement; M100-S15 2005, Clinical and Laboratory Standards Institute, Wayne, PA.